2nd Quarter - Report

BAKER & HOSTETLER LLP for CELGENE CORPORATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. Medicare reimbursement for transformative therapies. H.R. 1409, the "Cancer Drug Parity Act". H.R. 2051, the "FAST Generics Act". H.R. 2077, the "Restoring the Patient's Voice Act".

LobbyistCovered position, as disclosed
ADAM HIGGINS —
CHRIS JONES —
TYLER THOMPSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2077 (115th), H.R. 2051 (115th), H.R. 1409 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.